Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections
- 1 March 2012
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 133 (3) , 257-279
Abstract
No abstract availableKeywords
This publication has 226 references indexed in Scilit:
- High levels of serum matrix metalloproteinases in dogs with natural visceral leishmaniosis: A preliminary reportThe Veterinary Journal, 2011
- Toxoplasma gondii toxolysin 4 is an extensively processed putative metalloproteinase secreted from micronemesMolecular and Biochemical Parasitology, 2011
- Murine visceral leishmaniasis: IgM and polyclonal B‐cell activation lead to disease exacerbationEuropean Journal of Immunology, 2010
- Chagas diseaseThe Lancet, 2010
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2010
- Toxoplasmosis: A history of clinical observationsInternational Journal for Parasitology, 2009
- Diagnosis and management of the neurological complications of falciparum malariaNature Reviews Neurology, 2009
- Metalloproteinases and their inhibitors: Regulators of wound healingThe International Journal of Biochemistry & Cell Biology, 2008
- In vitro evidence for metallopeptidase participation in hepatocyte damage induced by Leishmania chagasi-infected macrophagesActa Tropica, 2008
- Control of matrix metalloproteinase catalytic activityMatrix Biology, 2007